Fortress Biotech (FBIO) Return on Assets (2016 - 2025)
Fortress Biotech (FBIO) has 13 years of Return on Assets data on record, last reported at 0.51% in Q3 2025.
- For Q3 2025, Return on Assets rose 36.0% year-over-year to 0.51%; the TTM value through Sep 2025 reached 0.51%, up 36.0%, while the annual FY2024 figure was 0.78%, 11.0% down from the prior year.
- Return on Assets reached 0.51% in Q3 2025 per FBIO's latest filing, up from 0.64% in the prior quarter.
- Across five years, Return on Assets topped out at 0.28% in Q1 2021 and bottomed at 0.97% in Q2 2023.
- Average Return on Assets over 5 years is 0.61%, with a median of 0.64% recorded in 2025.
- Peak YoY movement for Return on Assets: fell -27bps in 2023, then skyrocketed 36bps in 2025.
- A 5-year view of Return on Assets shows it stood at 0.46% in 2021, then crashed by -45bps to 0.67% in 2022, then tumbled by -45bps to 0.97% in 2023, then increased by 14bps to 0.83% in 2024, then skyrocketed by 39bps to 0.51% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Assets were 0.51% in Q3 2025, 0.64% in Q2 2025, and 0.62% in Q1 2025.